Alternatives to FORE Biotherapeutics

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-powered spatial biology platform for precision medicine and drug development.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Harnessing genetic data for digital insights in rare and germline disorders.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Developing novel diagnostics to predict patient response to immunotherapy.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

Transforming healthcare by turning scientific fiction into scientific facts.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

Bioinformatics platform for rapid discovery and validation of precision mental health treatments.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Therapeutics company developing novel treatments for complex diseases.

Early-stage clinical company developing smart targeted radioligands for precision oncology.

Develops AI-powered decision support tools for personalized medical data interpretation and prediction.

Leveraging the adaptive immune system to diagnose and treat disease.

Biotechnology company personalizing medical cannabis treatment using metabolic biomarker analysis.

Global leader in enzymatic therapeutics for non-surgical tissue repair, replacing existing standards of care.

A medical platform connecting patients and physicians with genetic expertise.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered blood analysis for precise substance tracing and classification in healthcare and research.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Developing engineered biologics to harness the immune system for disease treatment.

Microbiome technology platform for developing novel therapeutics.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

AI-powered platform to predict and prevent adverse drug reactions, reducing hospitalizations.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

AI-powered platform enhancing surgical precision and patient outcomes through data-driven recommendations.

Medical device company developing advanced sensor technology for oncology treatment.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Advanced diagnostics for preventative health and personalized cancer treatment using AI and genomics.

Personalized medical testing tool to optimize drug therapy for depression.

Biomedical platform with intelligent search for medical citations and clinical trial recruitment.

AI-powered blood test for early cancer detection and subtyping.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered platform for personalized cell therapy development and manufacturing.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

AI-powered breast cancer detection and risk assessment solutions.

Data-driven software solutions for precision medicine and pharmaceutical development.

Biotech company using AI and computational platforms to design novel peptide therapeutics.